Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 2
2012 1
2013 1
2014 3
2015 3
2016 9
2017 6
2018 5
2019 9
2020 4
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Peptide-based PET quantifies target engagement of PD-L1 therapeutics.
Kumar D, Lisok A, Dahmane E, McCoy M, Shelake S, Chatterjee S, Allaj V, Sysa-Shah P, Wharram B, Lesniak WG, Tully E, Gabrielson E, Jaffee EM, Poirier JT, Rudin CM, Gobburu JV, Pomper MG, Nimmagadda S. Kumar D, et al. Among authors: lisok a. J Clin Invest. 2019 Feb 1;129(2):616-630. doi: 10.1172/JCI122216. Epub 2019 Jan 7. J Clin Invest. 2019. PMID: 30457978 Free PMC article.
Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer.
De Silva RA, Kumar D, Lisok A, Chatterjee S, Wharram B, Venkateswara Rao K, Mease R, Dannals RF, Pomper MG, Nimmagadda S. De Silva RA, et al. Among authors: lisok a. Mol Pharm. 2018 Sep 4;15(9):3946-3952. doi: 10.1021/acs.molpharmaceut.8b00399. Epub 2018 Aug 10. Mol Pharm. 2018. PMID: 30037229 Free PMC article.
PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.
Lesniak WG, Chatterjee S, Gabrielson M, Lisok A, Wharram B, Pomper MG, Nimmagadda S. Lesniak WG, et al. Among authors: lisok a. Bioconjug Chem. 2016 Sep 21;27(9):2103-10. doi: 10.1021/acs.bioconjchem.6b00348. Epub 2016 Aug 9. Bioconjug Chem. 2016. PMID: 27458027 Free PMC article.
Rapid PD-L1 detection in tumors with PET using a highly specific peptide.
Chatterjee S, Lesniak WG, Miller MS, Lisok A, Sikorska E, Wharram B, Kumar D, Gabrielson M, Pomper MG, Gabelli SB, Nimmagadda S. Chatterjee S, et al. Among authors: lisok a. Biochem Biophys Res Commun. 2017 Jan 29;483(1):258-263. doi: 10.1016/j.bbrc.2016.12.156. Epub 2016 Dec 24. Biochem Biophys Res Commun. 2017. PMID: 28025143 Free PMC article.
Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide.
Lesniak WG, Mease RC, Chatterjee S, Kumar D, Lisok A, Wharram B, Kalagadda VR, Emens LA, Pomper MG, Nimmagadda S. Lesniak WG, et al. Among authors: lisok a. Mol Imaging. 2019 Jan-Dec;18:1536012119852189. doi: 10.1177/1536012119852189. Mol Imaging. 2019. PMID: 31187691 Free PMC article.
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.
Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG. Banerjee SR, et al. Among authors: lisok a. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2545-2557. doi: 10.1007/s00259-019-04434-0. Epub 2019 Aug 10. Eur J Nucl Med Mol Imaging. 2019. PMID: 31399803 Free PMC article.
A PSMA-targeted theranostic agent for photodynamic therapy.
Chen Y, Chatterjee S, Lisok A, Minn I, Pullambhatla M, Wharram B, Wang Y, Jin J, Bhujwalla ZM, Nimmagadda S, Mease RC, Pomper MG. Chen Y, et al. Among authors: lisok a. J Photochem Photobiol B. 2017 Feb;167:111-116. doi: 10.1016/j.jphotobiol.2016.12.018. Epub 2016 Dec 18. J Photochem Photobiol B. 2017. PMID: 28063300 Free PMC article.
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page